[Changes induced by S-adenosylmethionine (SAM) in the cholesterol and triglyceride plasma levels and in the beta-alpha lipoprotein ratio in cases of hyperlipemia. (Preliminary note)].
D000241:Adenosine / Q000627:therapeutic use*; D000368:Aged; D002784:Cholesterol / Q000097:blood*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008053:Lipid Mobilization / Q000187:drug effects; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008715:Methionine / Q000627:therapeutic use*; D008875:Middle Aged; D012436:S-Adenosylmethionine / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood*
D008074:Lipoproteins; D014280:Triglycerides; D012436:S-Adenosylmethionine; D002784:Cholesterol; D008715:Methionine; D000241:Adenosine
Modificazioni della colesterolemia, della trigliceridemia e del rapporto beta-alpha lipoproteico indotte dalla s-adenosilmetionina (SAM) in casi di iperdislipidemia. (Nota preventiva.